Literature DB >> 11832639

Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.

A Mishra1, S K Mishra.   

Abstract

BACKGROUND AND AIM: The presence of thyroid nodules with Graves' disease raises concern about co-existent thyroid malignancy. The objective of this study is to evaluate the risk of thyroid carcinoma and the need for surgical intervention in, patients with Graves' disease with co-existent nodules in an endemically iodine deficient area (IDA). SUBJECTS AND METHODS: Retrospective study of 130 surgically managed patients of Graves' disease (1990-1999). Out of these 35 (26.9%) cases had palpable nodules. No patient had history of previous head and neck irradiation or radioiodine therapy. The clinico-pathological findings and follow-up of these cases were noted.
RESULTS: Mean age of patients with nodules was 40.2 +/- 9.5 years and male to female ratio was 1:2.2. The overall incidence of thyroid carcinoma in Graves' disease was 6.2% (8/130 cases), while the incidence, in cases having nodule with Graves' disease was 17.1% (6/35 cases). The median age of patients with carcinoma was 45 years (5 women and 1 man). Besides laboratory investigations for hyperthyroidism, preoperative investigations included fine needle aspiration cytology (FNAC) and thyroid scintigraphy in 29 and 25 cases respectively. Incidence of malignancy in palpable cold nodules was 20%. FNAC could not predict malignancy with certainty in any of these cases. Five patients had papillary thyroid carcinoma while one had follicular carcinoma. Median tumour diameter was 10 mm. Tumour was multi-centric in two cases while one case had metastases to cervical lymph node. In follow-up (median =5.5 years) one patient died of unrelated cause, while rest are alive with no evidence of disease.
CONCLUSIONS: Nodules are frequently associated with Graves' disease in IDA. Incidence of carcinoma is high in palpable cold nodule. We recommend early thyroidectomy in these cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11832639

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  8 in total

1.  Marine-Lenhart syndrome.

Authors:  Mehtap Cakir
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

2.  Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.

Authors:  P V Pradeep; Amit Agarwal; Mukta Baxi; Gaurav Agarwal; Sushil Kumar Gupta; S K Mishra
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Thyroid cancer in Plummer's disease.

Authors:  Queenie Guinto Ngalob; Iris Thiele Isip-Tan
Journal:  BMJ Case Rep       Date:  2013-03-01

4.  Predictive factors of thyroid cancer in patients with Graves' disease.

Authors:  Meng Ren; Mu Chao Wu; Chang Zhen Shang; Xiao Yi Wang; Jing Lu Zhang; Hua Cheng; Ming Tong Xu; Li Yan
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

5.  Nodular Graves' disease with medullary thyroid cancer.

Authors:  Shoukat Hussain Khan; Tanveer Ahmed Rather; Rumana Makhdoomi; Dharmender Malik
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

6.  Identifying Marine-Lenhart syndrome on a (99m)Tc-pertechnetate thyroid scan.

Authors:  Nishikant A Damle; Rohini Mishra
Journal:  Indian J Endocrinol Metab       Date:  2013-03

7.  Pertechnetate thyroid scan in Marine-Lenhart syndrome.

Authors:  Jayanthi Roop Mohan; Sampath Santhosh; Ashwani Sood; Anish Bhattacharya; Bhagwant Rai Mittall
Journal:  Indian J Nucl Med       Date:  2013-04

8.  A Rare Presentation of Autonomously Functioning Papillary Thyroid Cancer: Malignancy in Marine-Lenhart Syndrome Nodule.

Authors:  Mehmet Uludag; Nurcihan Aygun; Alper Ozel; Feyza Yener Ozturk; Rabia Karasu; Banu Yilmaz Ozguven; Bulent Citgez; Mehmet Mihmanli; Adnan Isgor
Journal:  Case Rep Surg       Date:  2016-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.